"Sarcoma, Ewing" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A malignant tumor of the bone which always arises in the medullary tissue, occurring more often in cylindrical bones. The tumor occurs usually before the age of 20, about twice as frequently in males as in females.
| Descriptor ID |
D012512
|
| MeSH Number(s) |
C04.557.450.565.575.650.800 C04.557.450.795.620.800
|
| Concept/Terms |
Sarcoma, Ewing- Sarcoma, Ewing
- Sarcoma, Ewing's
- Sarcoma, Ewings
- Ewing's Sarcoma
- Ewings Sarcoma
- Ewing's Tumor
- Ewings Tumor
- Tumor, Ewing's
- Ewing Sarcoma
- Ewing Tumor
- Tumor, Ewing
|
Below are MeSH descriptors whose meaning is more general than "Sarcoma, Ewing".
Below are MeSH descriptors whose meaning is more specific than "Sarcoma, Ewing".
This graph shows the total number of publications written about "Sarcoma, Ewing" by people in this website by year, and whether "Sarcoma, Ewing" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 2 | 1 | 3 |
| 1995 | 1 | 0 | 1 |
| 1996 | 4 | 3 | 7 |
| 1997 | 0 | 1 | 1 |
| 1998 | 2 | 2 | 4 |
| 1999 | 2 | 1 | 3 |
| 2000 | 2 | 2 | 4 |
| 2001 | 2 | 3 | 5 |
| 2002 | 0 | 2 | 2 |
| 2003 | 2 | 1 | 3 |
| 2004 | 1 | 1 | 2 |
| 2005 | 8 | 1 | 9 |
| 2006 | 3 | 1 | 4 |
| 2007 | 9 | 2 | 11 |
| 2008 | 9 | 2 | 11 |
| 2009 | 6 | 1 | 7 |
| 2010 | 7 | 3 | 10 |
| 2011 | 8 | 1 | 9 |
| 2012 | 5 | 4 | 9 |
| 2013 | 8 | 1 | 9 |
| 2014 | 6 | 3 | 9 |
| 2015 | 7 | 2 | 9 |
| 2016 | 7 | 1 | 8 |
| 2017 | 8 | 3 | 11 |
| 2018 | 7 | 1 | 8 |
| 2019 | 7 | 2 | 9 |
| 2020 | 6 | 2 | 8 |
| 2021 | 4 | 1 | 5 |
| 2022 | 8 | 0 | 8 |
| 2023 | 8 | 0 | 8 |
To return to the timeline,
click here.
Below are the most recent publications written about "Sarcoma, Ewing" by people in Profiles.
-
Children's Oncology Group's 2023 blueprint for research: Epidemiology. Pediatr Blood Cancer. 2023 09; 70 Suppl 6:e30566.
-
Dissociation protocols used for sarcoma tissues bias the transcriptome observed in single-cell and single-nucleus RNA sequencing. BMC Cancer. 2023 May 31; 23(1):488.
-
Cumulative burden of late, major surgical intervention in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study (CCSS) cohort. Lancet Oncol. 2023 06; 24(6):691-700.
-
Treatment outcomes of extraskeletal Ewing sarcoma. J Surg Oncol. 2023 Jul; 128(1):105-110.
-
Targeted long-read sequencing of the Ewing sarcoma 6p25.1 susceptibility locus identifies germline-somatic interactions with EWSR1-FLI1 binding. Am J Hum Genet. 2023 03 02; 110(3):427-441.
-
Equivocal end-of-therapy imaging findings do not predict a higher risk of local relapse after definitive radiotherapy in pediatric Ewing sarcoma and rhabdomyosarcoma. Pediatr Blood Cancer. 2023 05; 70(5):e29989.
-
Modeling Ewing Sarcoma Lung Metastasis. Curr Protoc. 2023 Feb; 3(2):e670.
-
Vincristine-Induced Acrocyanosis and Erythema Pernio. J Prim Care Community Health. 2023 Jan-Dec; 14:21501319231181879.
-
Ewing sarcoma of Hoffa fat pad in the knee: a case report and review of the literature on primary intraarticular sarcomas and Hoffa fat pad masses. Skeletal Radiol. 2023 Jul; 52(7):1415-1420.
-
A Phase I/II Trial of Nivolumab plus Ipilimumab in Children and Young Adults with Relapsed/Refractory Solid Tumors: A Children's Oncology Group Study ADVL1412. Clin Cancer Res. 2022 12 01; 28(23):5088-5097.